Pingping Hu
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 7
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 4
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Jiajun Du (6 shared papers)Hongchang Shen (4 shared papers)Keke Sun (3 shared papers)Cheng Zhi Huang (2 shared papers)Liqiang Chen (2 shared papers)Lingfei Luo (1 shared paper)Li Zhang (1 shared paper)Sizhou Huang (1 shared paper)
- Journals
- PLoS ONE (3 papers)Translational Lung Cancer Research (3 papers)Annals of Translational Medicine (2 papers)Neuromodulation Technology at the Neural Interface (2 papers)Technology in Cancer Research & Treatment (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Pingping Hu
62 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Oncology 357
- Cancer Research 176
- Gastroenterology 48
- Pulmonary and Respiratory Medicine 165
- Immunology 104
Countries citing papers authored by Pingping Hu
This map shows the geographic impact of Pingping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Hu more than expected).
Fields of papers citing papers by Pingping Hu
This network shows the impact of papers produced by Pingping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Hu. The network helps show where Pingping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 149 | |
| 2 | 2014 | 132 | |
| 3 | 2019 | 130 | |
| 4 | 2018 | 47 | |
| 5 | 2017 | 45 | |
| 6 | 2017 | 43 | |
| 7 | 2014 | 38 | |
| 8 | 2018 | 33 | |
| 9 | 2013 | 31 | |
| 10 | 2015 | 31 | |
| 11 | 2021 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2013 | 24 | |
| 14 | 2013 | 24 | |
| 15 | 2018 | 24 | |
| 16 | 2017 | 20 | |
| 17 | 2017 | 20 | |
| 18 | 2013 | 16 | |
| 19 | 2015 | 15 | |
| 20 | PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma. | 2015 | 14 |
About Pingping Hu
Pingping Hu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Plant Science, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Research Studies (4 papers), Immune cells in cancer (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Immunotherapy and Immune Responses (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (357 citations), Cancer Research (176 citations), Gastroenterology (48 citations), Pulmonary and Respiratory Medicine (165 citations) and Immunology (104 citations). Pingping Hu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jiajun Du, Hongchang Shen, Keke Sun, Cheng Zhi Huang, Liqiang Chen, Lingfei Luo, Li Zhang, Sizhou Huang, Yuemei Xu and Qi Liu. Their work appears in journals such as PLoS ONE, Translational Lung Cancer Research, Annals of Translational Medicine, Neuromodulation Technology at the Neural Interface and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.